TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the addition of TNFerade™ to pre-operative
chemoradiotherapy increases the number of pathologic complete responses when compared to
pre-operative chemoradiotherapy alone as assessed following complete surgical resection of
primary rectal cancer.